| Fund Description |
| ProShares UltraShort Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the inverse (opposite) of the daily performance of the NASDAQ Biotechnology Index. |
| Fund Profile |
| Fund Name |
ProShares UltraShort Nasdaq Biotechnology |
| Fund Exchange Ticker |
BIS |
| Fund Sponsor |
ProShares |
| Fund ISIN |
US74347G8380 |
| Net Expense Ratio |
0.95 % |
| Fund Inception Date |
7 April 2010 |
| Fund Legal Structure |
ETF (Open end fund) |
| Exchange |
NASDAQ |
| Listing Country Code |
US |
| Fund Investment Objective |
| ETF Type Specific |
Equity - Leveraged / Inverse |
| Asset Class |
Equities (Stocks) |
| Index Linked |
Passive |
| Index Name |
NASDAQ Biotechnology Index |
| Index Provider |
Nasdaq |
| Currency Hedged |
No |
| Inverse / Leveraged |
Inverse (-2x) |
| Developed / Emerging |
Developed Market Funds |
| Market Capitalization Range |
Broad Market / Multi-Cap |
| Growth Value |
Core / Blend |
| Continent |
North America |
| Key Statistics |
| Return As of Date |
1 December 2023 |
| Asset Under Management |
4.45 Million (USD) |
| 1 Month Total Return |
-6.43 % |
| Year To Date Return |
15.63 % |
| 1 Year Total Return |
-9.77 % |
| 3 Year Annualized Total Return |
-7.86 % |
| NAV |
22.6684 |
| Share Outstanding |
196,100 |